MAPT and supranuclear palsy, progressive, 1: Colocalization of [18F]PI-2620 binding with 4R tau in micro-autoradiography [76] and quantitative agreement of autoradiography and immunohistochemistry [66, 78] as well as in vivo discrimination of PSP [21] and CBS [4] from controls highlight the potential of this radioligand.